Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ovid Therapeutics Inc (DE:1OT)
FRANKFURT:1OT
Ovid Therapeutics (1OT) Stock Price & Analysis
0 Followers
1OT Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.46 - €3.68
Previous Close€3.08
Volume0.00
Average Volume (3M)N/A
Market Cap
€202.22M
Enterprise Value€118.38M
Total Cash (Recent Filing)$105.83M
Total Debt (Recent Filing)$16.00M
Price to Earnings (P/E)N/A
Beta0.14
Next Earnings
May 07, 2024EPS Estimate
-€0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding70,709,857
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.46
Price to Sales (P/S)556.01
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue302.20
Enterprise Value/Gross Profit302.23
Enterprise Value/Ebitda-2.33
Forecast
1Y Price Target
€7.68Price Target Upside172.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Ovid Therapeutics News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.77% Other Institutional Investors
99.23% Public Companies and
Individual Investors
1OT FAQ
What was Ovid Therapeutics Inc’s price range in the past 12 months?
Ovid Therapeutics Inc lowest stock price was €2.46 and its highest was €3.68 in the past 12 months.
What is Ovid Therapeutics Inc’s market cap?
Currently, no data Available
When is Ovid Therapeutics Inc’s upcoming earnings report date?
Ovid Therapeutics Inc’s upcoming earnings report date is May 07, 2024 which is in 4 days.
How were Ovid Therapeutics Inc’s earnings last quarter?
Ovid Therapeutics Inc released its earnings results on Mar 08, 2024. The company reported -€0.205 earnings per share for the quarter, missing the consensus estimate of -€0.047 by -€0.159.
Is Ovid Therapeutics Inc overvalued?
According to Wall Street analysts Ovid Therapeutics Inc’s price is currently Undervalued.
Does Ovid Therapeutics Inc pay dividends?
Ovid Therapeutics Inc does not currently pay dividends.
What is Ovid Therapeutics Inc’s EPS estimate?
Ovid Therapeutics Inc’s EPS estimate is -€0.21.
How many shares outstanding does Ovid Therapeutics Inc have?
Currently, no data Available
What happened to Ovid Therapeutics Inc’s price movement after its last earnings report?
Ovid Therapeutics Inc reported an EPS of -€0.205 in its last earnings report, missing expectations of -€0.047. Following the earnings report the stock price went down -1.379%.
Which hedge fund is a major shareholder of Ovid Therapeutics Inc?
Among the largest hedge funds holding Ovid Therapeutics Inc’s share is Driehaus Capital Management LLC. It holds Ovid Therapeutics Inc’s shares valued at N/A.
---
Ovid Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€7.68 (172.47% Upside)
€7.68 (172.47% Upside)
Blogger Sentiment
Bullish
DE:1OT Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $50.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.72%
12-Months-Change
Fundamentals
Return on Equity
-47.57%
Trailing 12-Months
Asset Growth
-7.24%
Trailing 12-Months
Company Description
Ovid Therapeutics Inc
Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
---
1OT Stock 12 Months Forecast
Average Price Target
€7.68
▲(172.47% Upside)
Technical Analysis
Ovid Therapeutics
―
Anavex Life Sciences
―
Fennec Pharmaceuticals
―
Avrobio
―
Anixa Biosciences
―
Best Analysts Covering 1OT
1 Year
1 Year Success Rate
8/12 ratings generated profit
1 Year Average Return
+69.42%
assigned a buy rating 2 months ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +69.42% per trade.
---